Your browser doesn't support javascript.
loading
VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases.
Quinn, James P; Kandigian, Savannah E; Trombetta, Bianca A; Arnold, Steven E; Carlyle, Becky C.
Affiliation
  • Quinn JP; Department of Neurology, Alzheimer's Clinical & Translational Research Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA.
  • Kandigian SE; Department of Neurology, Harvard Medical School, Boston, MA 02115, USA.
  • Trombetta BA; Department of Neurology, Alzheimer's Clinical & Translational Research Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA.
  • Arnold SE; Department of Neurology, Harvard Medical School, Boston, MA 02115, USA.
  • Carlyle BC; Department of Neurology, Alzheimer's Clinical & Translational Research Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA.
Brain Commun ; 3(4): fcab261, 2021.
Article in En | MEDLINE | ID: mdl-34778762
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Brain Commun Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Brain Commun Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom